13 Apr Novacyt raises €2.2M to accelerate NOVAPREP launch in China and announces strong first quarter sales growth
Posted at 15:46h in Novacyt Group
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces a private equity placement financing of €2.2m. This new financing will be used to accelerate the launch of NOVAprep® into China with its distribution partner Leica Biosystems, now scheduled for Q2 2015. This follows the successful financing of €3.1m in December 2014.